Session Details

F075 Vascular Anomalies: Classification, Clinical Challenges, and Management Update

Mon, Mar 22, 9:00 AM - 11:00 AM
2 CME Available Forum

DESCRIPTION

Dermatologists play a primary role in diagnosing and directing the management of vascular anomalies. Over the last decade there have been significant developments in the understanding of the pathogenesis of vascular anomalies which have impacted clinical practice. In this session, experts in the field will discuss key topics and literature relating to the evaluation and management of vascular anomalies. Included topics will cover important advances in the literature, laser management of vascular anomalies, management of complicated infantile hemangiomas and PHACE syndrome and evolving targeted therapies for vascular anomalies.

LEARNING OBJECTIVES

1.

Consider and examine recent key publications from the vascular anomalies literature

2.

Develop tools for laser therapy for infantile hemangiomas, port wine birthmarks and other vascular malformations

3.

Describe new and emerging targeted therapies for patients with complex vascular anomalies and related syndromes

SCHEDULE

3:30 PM

Literature Every Vascular Anomalies Expert Should Know

Maria Cecilia Garzon, MD, FAAD

3:50 PM

Vascular Anomalies in the Era of Targeted Therapies

Beth Ann Drolet, MD, FAAD

4:10 PM

PHACE syndrome: Updates and Controversies

Dawn H. Siegel, MD, FAAD

4:30 PM

Hemangiomas in Pre-Term Infants: Isights from the GESTA study

Ilona J. Frieden, MD, FAAD

4:50 PM

Laser Management of Vascular Anomalies

Erin F. Mathes, MD, FAAD

DIRECTOR

Sheilagh M. Maguiness, MD, FAAD

Sheilagh M. Maguiness, MD, FAAD

University of Minnesota

SPEAKERS

Beth Ann Drolet, MD, FAAD

Beth Ann Drolet, MD, FAAD

Ilona J. Frieden, MD, FAAD

Ilona J. Frieden, MD, FAAD

UCSF

Maria Cecilia Garzon, MD, FAAD

Maria Cecilia Garzon, MD, FAAD

Erin F. Mathes, MD, FAAD

Erin F. Mathes, MD, FAAD

Dawn H. Siegel, MD, FAAD

Dawn H. Siegel, MD, FAAD

DISCLOSURES

Beth Ann Drolet, MD, FAAD

Arkayli Biosciences – Founder(Stock);

Ilona J. Frieden, MD, FAAD

Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Palvella Therapeutics – Consultant (1099 relationship)(Honoraria); Pierre Fabre Dermatologie – Consultant (1099 relationship)(Honoraria);

Maria Cecilia Garzon, MD, FAAD

No financial relationships exist with ineligible companies.

Sheilagh M. Maguiness, MD, FAAD

DYPER – Other(Fees); Galderma – Advisory Board(Honoraria); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Stryke Club LLC – Founder(No Compensation Received);

Erin F. Mathes, MD, FAAD

Novartis – Consultant (1099 relationship)(Fees);

Dawn H. Siegel, MD, FAAD

No financial relationships exist with ineligible companies.